Differences In Disease Prevalence As A Source Of The U.S.-European Health Care Spending Gap
Open Access
- 1 January 2007
- journal article
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 26 (6) , w678-w686
Abstract
The United States spends more on health care than any European country. Previous studies have sought to explain these differences in terms of system capacity, access to technologies, gross domestic product, and prices. We examine differences in disease prevalence and treatment rates for ten of the most costly conditions between the United States and ten European countries using surveys of the noninstitutionalized population age fifty and older. Disease prevalence and rates of medication treatment are much higher in the United States than in these European countries. Efforts to reduce the U.S. prevalence of chronic illness should remain a key policy goal.Keywords
This publication has 10 references indexed in Scilit:
- The Value Of Antihypertensive Drugs: A Perspective On Medical InnovationHealth Affairs, 2007
- Commentary on Getzen's “Aggregation and the Measurement of Health Care Costs”Health Services Research, 2006
- Disease and Disadvantage in the United States and in EnglandJAMA, 2006
- Why Do Europeans Smoke More than Americans?2006
- The Rise In Health Care Spending And What To Do About ItHealth Affairs, 2005
- Secular Trends in Cardiovascular Disease Risk Factors According to Body Mass Index in US AdultsJAMA, 2005
- U.S. Health Care Spending In An International ContextHealth Affairs, 2004
- Cancer Trends in the United States--A View From EuropeJNCI: Journal of the National Cancer Institute, 2003
- Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001JAMA, 2003
- The Disease Burden Associated With Overweight and ObesityJAMA, 1999